ICW Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $513K | Buy |
1,264
+161
| +15% | +$65.3K | 0.2% | 119 |
|
2025
Q1 | $549K | Buy |
1,103
+16
| +1% | +$7.96K | 0.22% | 116 |
|
2024
Q4 | $566K | Buy |
1,087
+129
| +13% | +$67.1K | 0.24% | 115 |
|
2024
Q3 | $593K | Buy |
958
+41
| +4% | +$25.4K | 0.25% | 112 |
|
2024
Q2 | $507K | Sell |
917
-12
| -1% | -$6.64K | 0.23% | 115 |
|
2024
Q1 | $540K | Buy |
929
+17
| +2% | +$9.89K | 0.24% | 113 |
|
2023
Q4 | $484K | Buy |
912
+44
| +5% | +$23.4K | 0.24% | 112 |
|
2023
Q3 | $439K | Buy |
868
+184
| +27% | +$93.1K | 0.24% | 110 |
|
2023
Q2 | $357K | Buy |
684
+80
| +13% | +$41.8K | 0.19% | 115 |
|
2023
Q1 | $349K | Buy |
604
+16
| +3% | +$9.24K | 0.2% | 115 |
|
2022
Q4 | $324K | Buy |
588
+19
| +3% | +$10.5K | 0.19% | 114 |
|
2022
Q3 | $289K | Buy |
569
+6
| +1% | +$3.05K | 0.19% | 114 |
|
2022
Q2 | $306K | Buy |
563
+3
| +0.5% | +$1.63K | 0.19% | 116 |
|
2022
Q1 | $331K | Buy |
560
+22
| +4% | +$13K | 0.19% | 118 |
|
2021
Q4 | $359K | Buy |
538
+110
| +26% | +$73.4K | 0.2% | 117 |
|
2021
Q3 | $245K | Buy |
+428
| New | +$245K | 0.16% | 127 |
|